Two internal thoracic artery grafts are better than one  by Lytle, Bruce W. et al.
Objective: Does the use of bilateral internal thoracic artery (ITA) grafts
provide incremental benefit relative to the use of a single ITA graft?
Methods: We conducted a retrospective, nonrandomized, long-term
(mean follow-up interval of 10 postoperative years) study of patients
undergoing elective primary isolated coronary bypass surgery who
received either single (8123 patients) or bilateral ITA grafts (2001
patients), with or without additional vein grafts. Multiple statistical
methods including propensity score matching, and multivariable parsi-
monious and nonparsimonious risk factor analyses were used to address
the issues of patient selection and heterogeneity. Results: In-hospital mor-
tality was 0.7% for both the bilateral and single ITA groups. Survival
for the bilateral ITA group was 94%, 84%, and 67%, and for the single
ITA group 92%, 79%, and 64% at 5, 10, and 15 postoperative years,
respectively (P < .001). Death, reoperation, and percutaneous translu-
minal coronary angioplasty were more frequent for patients undergoing
single rather than bilateral ITA grafting, and this observation remained
true despite multiple adjustments for patient selection, sampling, and
length of follow-up. The differences between the bilateral and single ITA
groups were greatest in regard to reoperation. The extent of benefit of
bilateral ITA grafting varied according to patient-related variables, but
no patient subsets were identified for whom single ITA grafting could be
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T he strategy of using the left internal thoracic artery(LITA) as a graft to the left anterior descending
(LAD) coronary artery has become a standard part of
coronary bypass surgery. LITA-LAD grafts have high
long-term patency rates, graft atherosclerosis is rare,
and clinical studies have demonstrated improved long-
term survival and fewer repeat procedures and cardiac
events for patients receiving LITA-LAD grafts.1-4
Logic seems to dictate that adding the use of the right
internal thoracic artery (RITA) as a bypass graft might
further improve long-term outcomes. However, no
studies have clearly demonstrated incremental benefits
of bilateral ITA grafting over those achieved with an
LITA-LAD graft combined with saphenous vein
grafts.5-15
There are many possible reasons that it has been dif-
ficult to show a clinical advantage for the use of 2 ITA
grafts, including (1) the success of the single ITA graft
in achieving good outcomes for at least a decade,
requiring relatively long-term follow-up in a large
number of patients to demonstrate incremental benefit
of multiple ITA grafts; (2) the multiple factors leading
to the selection of patients to receive bilateral versus
single ITA grafts confounds the interpretation of appar-
ent benefits. 
In this observational, nonrandomized study, we have
compared outcomes for a large group of patients whose
primary elective bypass surgery included either the use
of 1 or both ITAs. The methods of comparison ad-
dressed pitfalls of using clinical experience to draw a
casual inference that include (1) patient selection,
potentially confounding the comparison, (2) patient
heterogeneity influencing the overall estimate of any
benefit because of patient mix, and (3) over-statement
of the magnitude and certainty of any benefit con-
tributed in part by the statistical methods used, as well
as from the use of a single experience. The outcome
end points that were studied were death from any
cause, cardiac reoperation for any reason, and percuta-
neous treatment of coronary artery disease (percuta-
neous transluminal coronary angioplasty, or PTCA). 
Patients and methods
Patient population. With the aid of a computerized pros-
pective cardiovascular information registry, we identified all
patients undergoing primary isolated revascularization using
both ITAs for bypass grafts during the years 1971 to 1989.
Those patients are termed the bilateral ITA group. The first
bilateral ITA operation at The Cleveland Clinic Foundation
was performed in 1971. Entry to the study was stopped in
1989 to provide a minimum 6-year follow-up interval for all
patients. Foreign patients were excluded from this group
because of anticipated difficulty in follow-up. From the group
of 2015 bilateral ITA patients identified, 14 patients were
undergoing emergency operation and were excluded from
further study because emergency operation is a factor that
strongly affects the selection of patients for arterial graft
operations. Therefore, aside from the exclusion of foreign
patients and the 14 patients undergoing emergency operation,
this represents a consecutive series of patients receiving bilat-
eral ITA grafts as a primary operation for isolated bypass
grafting.
In addition, through our cardiovascular information reg-
istry we have established a database of preoperative and peri-
operative data and have periodically conducted follow-up
studies involving the first 1000 patients per year undergoing
primary isolated elective (emergency operations excluded)
coronary artery bypass grafting. From those 1000 patient
cohorts undergoing surgery during the years 1971 to 1989, all
patients were identified who received 1 ITA graft and at least
1 saphenous vein–coronary artery bypass graft. There were
8123 such patients, termed the single ITA group. Some for-
eign patients were included in these cohorts. Preoperative
characteristics of both patient groups are listed in Appendix
1. No aspect of the surgical process was randomized for these
patients. Multiple strategies for myocardial protection were
used. The decision to use single or bilateral ITA grafts and the
vessels that were chosen to be grafted with those ITAs were
at the discretion of the attending surgeon. 
In the bilateral ITA group, 1693 patients (84.6%) received
2 ITA grafts, 292 (14.6%) received 3, and 16 (0.8%) received
4. The ITAs were used entirely as in situ grafts for 1744
(87.2%) patients, 248 (12.4%) patients received 1 free ITA
graft, and 9 received 2 free ITA grafts. Free grafts were per-
formed as aorta-coronary grafts. Major target vessels for the
ITA grafts were LAD and circumflex, 1217 patients (60.8%);
LAD and right coronary artery (RCA), 459 patients (22.9%);
and circumflex and RCA, 58 patients (3.0%). The rest of the
patients (13.3%) received grafts that involved at least 1 ITA
graft being used to graft a vessel classed as a diagonal coro-
nary artery. Ramus, or intermediate arteries, fell into this
classification. The details of the ITA grafting strategies are
listed in Appendix 2. Nineteen patients (0.9%) who received
concomitant gastroepiploic grafts and 4 (0.2%) who received
radial artery grafts were excluded from the multivariable
analyses at the request of one of the reviewers of this manu-
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predicted to provide an advantage. Conclusions: Patients who received 2
ITA grafts had decreased risks of death, reoperation, and angioplasty.
(J Thorac Cardiovasc Surg 1999;117:855-72)
script. In the single ITA group the ITA was used as a graft to
the LAD in 7147 patients, the LAD-diagonal in 144 patients,
the circumflex in 220 patients, the diagonal branch in 588
patients, the RCA in 22 patients, and the diagonal-circumflex
arteries in 2 patients. The patient numbers and percentages
according to the number of saphenous vein grafts received
were 0 saphenous grafts, 436 patients (21.8%); 1 graft, 750
patients (37.5%); 2 grafts, 599 patients (29.9%), 3 grafts, 182
patients (9.1%), 4 grafts, 31 patients (1.5%), and 5 saphenous
grafts, 3 patients (0.1%).
Routine follow-up by mail with supplemental telephone
follow-up has been conducted every 5 years for the single
ITA group. Patients in the bilateral ITA group were followed
up within 1 year of data analysis and had received at least 1
previous follow-up. Because of our interest in multiple arter-
ial grafting, most patients in the bilateral ITA group had been
followed up more than twice. The median follow-up interval
of hospital survivors was 10.13 years (mean 9.71 ± 3.0 years)
for the bilateral ITA group and 10.26 years (mean 10.80 ± 5.2
years) for the single ITA group. In the bilateral ITA group,
follow-up was incomplete for 51 patients. Of these 51
patients, 6 had 1 to 5 years of postoperative follow-up, 34, 5
to 10 years, and 5 more than 10 years. In the single ITA
group, 634 patients had incomplete follow-up, with 82 fol-
lowed up for 1 to 5 years, 198 for 5 to 10 years, and 189 more
than 10 years. The end points that were recorded were death
from any cause, cardiac reoperation for any reason, and
attempted percutaneous intervention for coronary artery dis-
ease (PTCA). When patients had incomplete follow-up they
were censored at the date of last follow-up.
Logistic regression analysis was used to determine impor-
tant predictors of in-hospital mortality. A logistic regression
model, adjusted for age and ITA group, was then fit with only
those variables that were significant in the stepwise model (P
< .05) to allow the maximum number of patients to be ana-
lyzed. The odds ratios and 95% confidence intervals have
been provided (Table I).
Analyses of time-related outcomes. The time-related out-
come events used to compare single to bilateral ITA grafting
were as follows: (1) death from any cause, including hospital
deaths; (2) cardiac reoperations; (3) death or reoperation
(reoperation-free survival); (4) percutaneous reinterventions
(PTCA).
Nonparametric estimates of survival, freedom from cardiac
reoperation, and freedom from PTCA were estimated for
each group by the method of Kaplan and Meier.16 The instan-
taneous risk of events across time (the hazard function) was
estimated by means of a parametric method that resolved the
number of hazard phases, identified the shape of the hazard
function, and estimated its parameters.17
Preliminary data analysis. Preliminary exploration of the
data with respect to each event considered included frequen-
cy data of preoperative baseline characteristics using the c 2
test to detect differences unlikely to be due to chance between
the 2 ITA groups. Mean values of continuous variables, such
as age, were compared by means of the Student t test.
Correlations were sought between variables. Life tables strat-
ified by categoric variables were explored. Because naturally
ordered variables, such as anginal symptoms and degree of
left ventricular function, and all continuous variables were
retained as such in the analyses, we investigated multiple
transformations of these variables by decile risk analysis to
best calibrate them in the risk factor models. These prelimi-
nary analyses were repeated in the case of hazard function
analyses for events subdivided according to the time phase of
their occurrence.
Data analysis. The primary objective of the data analysis
was the statistical estimation of the possible benefit of bilat-
eral ITA grafting on survival and freedom from interventions.
Other objectives included the assessment of the effect of
patient-related variables on outcome and the identification of
definable patient subgroups with particularly great or partic-
ularly little benefit from bilateral ITA grafting. The analysis
of possible benefit addressed confounding (patient selection)
by use of a propensity score, 18 heterogeneity (risk factors) by
multivariable risk factor analysis,19 and shrinkage (exaggera-
tion of benefit) by bootstrap resampling.20
Confounding (patient selection). Because use of bilateral
versus single ITA grafting did not involve randomized assign-
ment, patient selection bias was addressed by a matching
strategy for which a propensity score was used.18 The event
bilateral ITA (vs single ITA) grafting was analyzed, without
regard to any outcome, using logistic multivariable regres-
sion. The object was not to develop a parsimonious risk fac-
tor model, but to account for all known sources of potential
selection bias. Nevertheless, to accomplish this, a sequence
of intermediate modeling efforts was needed. First, a parsi-
monious model of individual factors (“main effects”) was
developed independently by P.H. and E.B. and the models
were reconciled. All factors listed in Appendix 3 were used,
but unlike the subsequent multivariable analyses of out-
comes, variables for individual surgeons were also incorpo-
rated, because they could be considered a source of selection
bias. Second, interactions among the variables in the parsi-
monious model were sought, these being dominated by age of
the patient and date of the operation. Finally, risk factors not
represented in the parsimonious model were incorporated.
These additional variables included anginal symptoms, histo-
ry of myocardial infarction, family history of coronary artery
disease, left main disease, hypertension, and chronic obstruc-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 5
Lytle et al   857
Table I. Logistic regression analysis: In-hospital death
Variable c 2 P value Odds ratio (95% CI)
BITA vs SITA .5 0.81 (0.45, 1.46)
Age 50-60* .5 1.33 (0.53, 3.37)
Age >60* .01 2.98 (1.25, 7.10)
Gender (female) <.001 2.51 (1.53, 4.14)
PVD <.001 2.87 (1.71, 4.82)
CI, Confidence interval; BITA, bilateral internal thoracic artery group; SITA,
single internal thoracic artery group; PVD, peripheral vascular disease.
*Compared with age less than 50 years.
tive pulmonary disease. The area under the receiver operating
characteristic (ROC) curve for this model was 0.91.
After completion of the propensity model, a propensity
score was calculated from the logistic equation for each
patient. The model predicted likelihoods of bilateral ITA
grafting (vs single ITA grafting) ranging from essentially 0%
to 99.7%. As suggested by Rubin,21 the patients were sorted
by propensity and compared within quintiles. Only 68
patients receiving bilateral ITA grafting were in the first 2
quintiles. However, bilateral and single ITA patients in quin-
tiles 3 through 5 were well matched with respect to patient
risk factors. Appendix 4 details the matching of quintiles 3
through 5 in regard to selected variables, but the bilateral
ITA–single ITA groups were similarly well matched for all
variables in Appendix 3. Thus the sample of “propensity-
matched patients” excludes the first 2 quintiles of single ITA
patients (3976 patients). The excluded patients were predict-
ed to receive bilateral ITA grafting with low probability for
any of a variety of reasons, and essentially did not match
bilateral ITA grafting cases for comparison purposes. The
propensity score was either retained as a logit unit score or
transformed into the probability domain (as the probability of
receiving bilateral ITA grafting). It was incorporated as a
continuous variable into outcomes analyses described below
to adjust for possible confounding.22
Heterogeneity (risk factors). A number of risk factors (case
mix) influence each of the outcomes studied; the prevalence
of some of these differed between the groups (Appendix 1).
These differences may have increased or reduced the appar-
ent benefit of bilateral versus single ITA grafting.
Importantly, these factors also could give insight into the
nature of the treatment and predict which patients are more or
less likely to benefit from treatment. Therefore risk factor
models were developed for the separate events, death, reop-
eration, and PTCA. 
Two multivariable risk factor models were used for 2 dif-
ferent purposes. Semiparametric Cox proportional hazards
regression was used to obtain average effects across time.23
Interactions of variables with the type of ITA grafting were
not considered to obtain a simple estimate of a possible ben-
efit of bilateral ITA grafting in the form of a single parameter
estimate. The second method used parametric, multiphase,
nonproportional hazards regression to obtain time-specific
effects.17
For the Cox proportional hazards regression, initial screen-
ing of potential risk factors was accomplished by forward
stepwise regression, followed by examination of interaction
terms. For the nonproportional hazards regression, a directed
technique of entry of variables into the multivariable risk fac-
tor model was used.18 Both forward stepwise and backward
variable elimination analysis supplemented this directed
technique, identifying the same model. Interactions among
variables were sought thereafter, including interactions with
type of grafting.
For the Cox proportional hazards model, results are pre-
sented in terms of the regression coefficients ± 1 standard
error and the hazard ratio and 95% confidence limits.
Nonproportional hazard regression coefficients are presented
± 1 standard error in a phase-specific fashion. The P value
criterion for retention of variables and interactions in the final
models was .05 for either method.
While these modeling efforts were performed quasi-inde-
pendently, after the development of each, differences
between models were examined, and the differences were
either reconciled or understood as genuine differences in the
models. Thus all final models represent the end product of a
joint statistical collaborative effort.
Confounding and heterogeneity. To maximally adjust the
estimate of possible benefit of bilateral ITA grafting, nonpar-
simonious regression models were developed in both the Cox
proportional and the parametric nonproportional hazards
domains with both the type of ITA grafting forced into the
model, as well as the most appropriate transformation of the
propensity score. Initially parsimonious models were devel-
oped using a P value criterion of .1, followed by investigation
of interaction terms (including interactions with type of graft-
ing in the case of the parametric nonproportional hazards
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Fig 1. Comparison of the bilateral ITA (BITA) and single ITA
(SITA) groups in terms of survival (A) and reoperation-free
survival (B). Numbers of patients surviving at selected fol-
low-up intervals are listed beneath part A.
A
B
modeling). Interactions were included only for P < .05. In
general, the variables found in the parsimonious aspects of
this modeling effort were identical to those in the analysis of
heterogeneity. Subsequently, variables were added to the
model, irrespective of P value, from each category of vari-
ables. Thus the final models always included gender, age (or
its transformation), body size (height or weight, whichever
was more significant), grade of anginal symptoms, degree of
left ventricular dysfunction, presence of congestive heart fail-
ure, history of previous myocardial infarction, family history
of coronary disease, smoking history, peripheral vascular dis-
ease, diabetes, hypertension, one or more variables concern-
ing the extent of coronary artery disease, date of operation,
and location of ITA grafts. In the case of the parametric non-
proportional hazards model, the same procedure was fol-
lowed for the hazard phase containing the largest number of
events; however, in the case of phases containing few events,
only that number of additional variables was added that was
less than half the number of events identified for that phase.
Shrinkage (exaggeration of benefit). All these analyses were
performed on the same groups of patients. This has the disad-
vantage that the apparent benefit may be inflated and the vari-
ance estimate too small, resulting in P values for the differ-
ence that are smaller than might be found in repeated similar
experiences. Various methods have been developed, therefore,
to “shrink” the estimates, yielding a more conservative, but
probably more accurate, estimate of benefit. In this study,
multiple patient samples, each equal in number to the total
propensity-matched sample size, were randomly drawn from
the existing patient population. Each sample was then ana-
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Table II. Incremental risk factors for death (Cox proportional hazards model for all patients), N = 10,098 (8123
SITA, 1975 BITA)
Incremental risk factors Coefficient ± SD Hazard ratio 95% CL P value
Demography
Women 0.162 ± 0.32 5.05 2.67-9.53 <.0001
Age
Older 0.100 ± 0.01 1.11 1.09-1.12* <.0001
Younger 1.01 ± 0.13 2.76 2.12-3.58† <.0001
Women + younger age (interaction) –0.024 ± 0.005 0.98 0.97-0.99‡ <.0001
Greater body mass index 0.006 ± 0.002 1.01 1.00-1.01 .004
Symptoms of reversible ischemia
More severe angina class 0.04 ± 0.02 1.05 1.01-1.08§ .01
Coronary disease
Greater left main disease 0.42 ± 0.08 1.52 1.30-1.77II <.0001
Right coronary artery occlusion ‡ 50% 0.113 ± 0.06 1.12 1.00-1.25 .048
Circumflex occlusion ‡ 70% 0.23 ± 0.04 1.26 1.16-1.37 <.0001
Left ventricular function
Higher grade of dysfunction 0.41 ± 0.10 1.51 1.23-1.85¶ <.0001
+ Younger age (interaction) –0.20 ± 0.08 0.82 0.69-0.97# .02
Chronic heart failure 0.60 ± 0.08 1.81 1.55-2.12 <.0001
History of myocardial infarction 0.182 ± 0.04 1.20 1.10-1.31 <.0001
Noncardiac comorbidity
Peripheral vascular disease 0.44 ± 0.05 1.56 1.40-1.73 <.0001
Smoking history 0.41 ± 0.04 1.50 1.38-1.63 <.0001
Pharmacologically treated diabetes 0.29 ± 0.12 1.33 1.06-1.68 .02
+ Younger age (interaction) 0.47 ± 0.14 1.59 1.20-2.11** .001
Hypertension 0.34 ± 0.05 1.41 1.27-1.56 <.0001
Operation
Single ITA grafting 0.186 ± 0.06 1.20 1.07-1.35 .001
ITA to LAD –0.122 ± 0.06 0.88 0.79-0.99 .04
Experience
Earlier date of operation 0.087 ± 0.03 1.09 1.03-1.15†† .002
CL, Confidence limits; ITA, internal thoracic artery.
*Per 1-year increase.
†Per unit change in [50/age]2 inverse squared transformation.
‡Per 1-year decrease (interaction in female patients).
§Per unit increase in anginal severity.
IIPer change from 0% to 100% [percent stenosis/100] scaled transformation.
¶Per unit increase in dysfunction.
#Per unit decrease in [age/50]2 scaled transformation (interaction with dysfunction).
**Per unit change in [50/age]2 inverse squared transformation (decrement in diabetic patients).
††Per unit change in [1/years since 1971] inverse transformation.
lyzed as though it were a new patient population and all coef-
ficients of the proportional and nonproportional hazards mod-
els adjusted for confounding and heterogeneity. This sampling
and analysis process was repeated 1000 times. This computer-
intensive process called bootstrapping yielded the most con-
servative estimate of the effect of arterial grafting strategy.20
Data in figures are presented with confidence limits equiv-
alent to 1 standard error. In tabular data means are presented
± 1 standard deviation.
Results
Patient characteristics. Appendix 1 shows the uni-
variate comparisons of the baseline differences be-
tween the entire bilateral ITA and single ITA groups.
There were statistically significant differences in regard
to gender, age, incidence of diabetes, family history of
coronary artery disease, preoperative functional class,
left ventricular function status, extent of disease (num-
ber of vessels stenotic), and greater than 70% LAD
lesion (all P < .001). All variable subgroups were well
represented in both the bilateral and single ITA groups
except that there were a small number of patients in the
bilateral ITA group who were 70 years old or older (62
patients).
In-hospital morbidity and mortality. Hospital death
occurred in 14 patients (0.7%) in the bilateral ITA group
and 58 patients (0.7%) in the single ITA group. Table I
contains the results of logistic regression analysis of the
variables in Appendix 1 in regard to their influence on
in-hospital mortality. The number of ITAs used as grafts
was not associated with mortality. The only morbid
event significantly different between the 2 groups was
sternal wound complications (bilateral ITA 50/2001,
2.5%, vs single ITA 115/8123, 1.4%) (P = .001).
Survival and reoperation. Late survival for the
entire bilateral ITA and single ITA groups is shown in
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Fig 2. Comparison of survival and reoperation hazard function curves in the propensity-matched patients (both P
< .0001) (bilateral [BITA], n = 1989; single [SITA], n = 4147). CABG, Coronary artery bypass grafting.
Table III. Average comparative risk of single vs. bilateral ITA grafting based on Cox proportional hazards
methodology 
Death Reoperation PTCA
Method of adjustment HR 95% CL HR 95% CL HR 95% CL
1. None, entire population, all follow-up 1.36 1.21-1.52 3.87 2.87-5.21 1.02 0.83-1.25
2. None, entire population, 12-year 1.42 1.27-1.60 3.83 2.81-5.22 0.95 0.78-1.17
follow-up
3. None, propensity-matched group 1.67 1.47-1.89 3.63 2.63-5.00 1.27 1.02-1.59
4. For confounding only 1.30 1.12-1.51 3.68 2.66-5.10 1.43 1.14-1.79
5. For heterogeneity only (parsimonious) 1.33 1.17-1.51 4.39 2.96-6.52 1.79 1.42-2.26
6. For confounding and heterogeneity 1.36 1.17-1.57 4.67 3.14-6.96 1.79 1.43-2.26
(nonparsimonious)
7. For confounding and heterogeneity, 1.35 1.16-1.56 4.91 3.30-7.55 1.84 1.46-2.30
bootstrap (nonparsimonious)
CL, Confidence limits; HR, hazard ratio; ITA, single internal thoracic artery graft.
Fig 1, along with the number of patients surviving at
selected follow-up intervals. Patients receiving a single
ITA graft had a higher late mortality than the patients
receiving bilateral ITA grafts. Risk factors for survival
were examined with a Cox regression (parsimonious)
multivariate model that included all patients (none
removed by virtue of propensity score) shown in Table
II. Parametric, nonproportional hazard models involv-
ing all patients produced similar results.
The survival curves for the propensity-matched bilat-
eral ITA and single ITA groups are shown in Fig 2.
Forty-six of the patients in the bilateral ITA group
underwent cardiac reoperation. For 32 patients the
reoperation was carried out solely for bypass grafting,
and the anatomic indications for surgery were progres-
sion of native vessel disease without graft failure (n =
2), graft failure alone (n = 9), a combination of native
vessel disease progression (n = 17), and unknown rea-
sons (n = 4). Of the 14 remaining patients who under-
went reoperation, the repeat procedure was for a valve
or aortic aneurysm surgery alone in 7. The other 7
patients underwent valve surgery and also received
bypass grafting, but in 4 of the patients the bypass
grafting was incidental. Reoperation-free survival of
the entire bilateral ITA and single ITA groups is shown
in Fig 1. Hazard-function curves for reoperation for the
propensity-matched groups are shown in Fig 2.
Analyses of differences in outcomes. The simplest
question of the study (Are 2 ITA grafts better than 1?)
is addressed quantitatively in Table III by means of
multiple statistical approaches. This table presents the
hazard ratios from Cox proportional hazard regression
models for each outcome (death, reoperation, PTCA)
and includes (1) a nonadjusted estimate based on the
entire bilateral ITA and single ITA population for all
follow-up available, (2) a nonadjusted estimate for the
entire population with follow-up truncated to 12 years
(because of small numbers of bilateral ITA patients fol-
lowed up for more than 12 years), (3) a nonadjusted
estimate for the propensity-matched patients for 12
years, (4) estimates adjusted for confounding only in
the propensity-matched groups (using the propensity
score), (5) estimates based on traditional parsimonious
modeling of the propensity-matched groups, (6) esti-
mates based on nonparsimonious adjustments for both
confounding and heterogeneity, and, finally, (7) esti-
mates based on the 1000 nonparsimonious bootstrap
models drawn from the propensity-matched groups
adjusted for both confounding and heterogeneity. The
benefit of bilateral ITA grafting is expressed by the
hazard ratio whose value is equal to 1 if the average
outcomes are equivalent and greater than 1 if outcomes
are better with 2 ITA grafts. The last line in Table III
produces the most conservative and believable set of
estimates. However, regardless of the adjustment tech-
niques used, the estimates are fairly similar and in all
cases outcomes were better for the patients with 2 ITA
grafts.
Bootstrap resampling was used to create 1000 differ-
ent patient populations to see if any of the populations
would exhibit a Cox regression hazard ratio of less than
1, indicating superiority of a single ITA graft for that
population. None did. The distribution of the Cox haz-
ard ratios for these bootstrap samples is shown in Fig 3.
The preceding analyses were designed to answer the
single question of the relative advantage of having 2
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Fig 3. Distribution of Cox hazard ratios for 1000 “bootstrap” samples tested for the influence of bilateral versus
single ITA grafts on the occurrence of death, PTCA, and reoperation. Any Cox hazard ratio greater than 1 indi-
cates an advantage for bilateral ITA grafting. All hazard ratios for all samples were greater than 1.
ITA grafts. To put that strategy in the context of other
risk factors, we studied the propensity-matched patient
sample with detailed risk factor analyses (parsimonious
multivariate models). Both Cox regression and nonpro-
portional hazard models confirmed that a single ITA
graft was a risk factor for all outcomes, but the level of
risk of a single ITA graft was estimated to be higher by
the nonproportional hazards method because that
method isolates its influence more specifically to the
late rising hazard phase. Nonproportional hazard mod-
els for the propensity-matched groups were developed
in regard to death (Table V), reoperation (Table VI),
and PTCA (Table VII).
Magnitude of the benefit of bilateral ITA graft-
ing. Because the occurrence of death, reoperation, and
PTCA are related to multiple variables other than sur-
gical strategy, estimation of the extent of benefit from
bilateral ITA grafting must adjust for these variables.
Nonproportional hazard equations were developed for
each patient in the propensity-matched population. All
the information regarding the variables in Appendix 3
were included in the equation, and that equation was
then solved twice—once as if the patient had received
1 ITA graft and once as if he or she had received 2 ITA
grafts. The predicted percentage difference in the
occurrence of death, reoperation, and PTCA by 12
postoperative years on the basis of 1 versus 2 ITA
grafts was then calculated for each patient. Those per-
centage differences are depicted in Fig 4, plotted
against the proportion of the population predicted to
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Table IV. Incremental risk factors for death (nonpro-
portional hazards parsimonious model): Propensity-
matched patients
Hazard phase
Incremental risk factor Early P Late P
Demography
Women › .0004 — —
Age
Older › <.0001 › <.0001
Younger — — › .01
Symptoms of reversible 
ischemia
More severe angina class — — › .003
Coronary disease
Greater left main disease — — › .02
Larger number of diseased — — › .006
systems
Left ventricular function
Higher grade of dysfunction › <.0001 › <.0001
+ Younger age (interaction) › .004
Chronic heart failure — — › <.0001
History of myocardial — — › .01
infarction
Noncardiac comorbidity
Peripheral vascular disease › <.0001 › <.0001
Smoking history — — › <.0001
Pharmacologically treated — — › .02
diabetes
+ Older age (interaction) — — › .02
+ Younger age (interaction) — — › .002
Hypertension — — › <.0001
Operation
Single ITA grafting — — › <.0001
ITA to LAD fl .01 — —
Experience
Earlier date of operation › .03 — —
ITA, Internal thoracic artery; LAD, left anterior descending coronary artery.
Table V. Incremental risk factors for reoperation
(nonproportional hazards parsimonious model):
Propensity-matched patients
Hazard phase
Incremental risk factor Early P Late P
Demography
Younger age — — › .003
Shorter height — — › .01
Left ventricular function 
Chronic heart failure — — › .01
Noncardiac comorbidity
Hypertension › .02 — —
Operation
Single ITA grafting › .003 › <.0001
ITA to LAD — — fl .004 
ITA to RCA — — › .01
Experience
Earlier date of operation › .07 — —
ITA, Internal thoracic artery; LAD, left anterior descending coronary artery;
RCA, right coronary artery system.
Table VI. Incremental risk factors for percutaneous
procedure (PTCA) (nonproportional hazards parsimo-
nious model)
Incremental risk factor Late hazard phase P
Demography
Younger age › <.0001
Coronary disease
RCA stenosis fl .002
Left ventricular function
Lower grade of dysfunction › .0004
History of myocardial infarction fl .01
+ Older age (interaction) › .01
Operation
Single ITA grafting › <.0001
Experience
More recent date of operation › <.0001
PTCA, Percutaneous transluminal coronary angioplasty; RCA, right coronary
artery system; ITA, internal thoracic artery.
experience that percentage difference in each event.
Bilateral ITA grafting was most protective against
reoperation. However, for all patients bilateral ITA
grafting was predicted to produce better outcomes in
regard to all adverse events (death, reoperation,
PTCA).
Examination of bilateral ITA grafting for specific
subgroups. Fig 4 indicates that although all patients
are estimated to have better outcomes with bilateral
ITA grafting, for some that benefit is relatively small,
particularly in regard to survival. Important prognostic
variables were examined to try to identify “low bene-
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Fig 4. Nonproportional hazard equations were solved twice for each propensity-matched patient, once as if the
patient had single ITA grafting and once as if the patient had bilateral ITA grafting. The distribution of the per-
centage differences in outcomes for all patients based on bilateral versus single ITA grafting are shown in this fig-
ure. All patients had better predicted outcomes with bilateral ITA grafting. The percentage of the patient popula-
tion is expressed vertically and the percent difference in the occurrence of each event is expressed horizontally.
The table details percent differences at selected percentages of the entire patient population.
Fig 5. Non-risk-adjusted age relation to survival and freedom from reoperation at 12 postoperative years for
propensity-matched patients based on nonproportional hazard equations. The survival curve confidence limits of
patients having bilateral (BITA) and single (SITA) ITA grafting overlap at young ages. Bilateral ITA grafting pro-
duces significantly better freedom from reoperation at all ages and better survival at older ages.
fit” groups. Fig 5 illustrates the non-risk-adjusted rela-
tionship of age to survival and freedom from reopera-
tion by 12 postoperative years for the propensity-
matched patients. For younger patients the
improvement in survival was small, as both bilateral
ITA and single ITA groups had favorable survival; how-
ever, younger patients in the single ITA group were at
a very high risk for reoperation, and bilateral ITA graft-
ing greatly decreased that risk. As patients aged the risk
of reoperation became less and the risk of death
became greater along with an increase of the effect of
bilateral ITA grafting in improving survival.
We also examined the propensity-matched patients in
regard to diabetes and left ventricular function. Fig 6
depicts survival for the bilateral ITA and single ITA
groups in regard to survival, showing that bilateral ITA
grafting produces improved outcomes for patients with
or without pharmacologically treated diabetes. Fig 7
examines unadjusted survival stratified by left ventric-
ular dysfunction (none or mild vs moderate or severe).
Again, the bilateral ITA grafting improves survival for
both subsets.
Thus, although the analyses depicted in Figs 3 and 4
indicate that “low benefit” groups do exist, particularly
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Fig 7. Twelve-year survival of patients having bilateral (BITA) or single (SITA) ITA grafting according to left ven-
tricular (LV) function (none or mild dysfunction vs moderate or severe dysfunction). For both ventricular func-
tion subgroups, survival was better for patients having bilateral ITA grafting.
Fig 6. Non-risk-adjusted survival curves for diabetic and nondiabetic patients according to bilateral (BITA) ver-
sus single (SITA) ITA grafting at 12 postoperative years. For both groups survival for patients having bilateral ITA
grafting was better.
in regard to survival, those groups are not completely
defined by the use of a single variable. Multiple vari-
ables are required to predict high and low benefit groups.
For illustration we used nonproportional hazard
equations (Tables IV and V) to examine the difference
based on bilateral versus single ITA grafting for
patients defined by multiple characteristics. Fig 8
depicts predicted outcomes for patient 1 (a 47-year-old
normotensive man with normal left ventricular func-
tion, class II angina, and 2-vessel disease) and patient 2
(a 64-year-old hypertensive man with a previous
myocardial infarction, 3-vessel disease, and moderate
impairment of left ventricular function). Patient 1 is
predicted to have excellent survival regardless of
whether he receives 1 or 2 ITA grafts, but he has a
much higher likelihood of reoperation (approximately
10% · 12 postoperative years) if he receives a single
ITA graft. Patient 2 has a worse survival outlook over-
all, but the risks of death and reoperation are both sig-
nificantly decreased by the use of 2 ITA grafts. Age,
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Fig 8. Predicted survival and reoperation hazard function curves according to 1 ITA versus 2 ITAs for a 47-year-
old normotensive man with 2-vessel disease and normal left ventricular function (patient 1) and for a 64-year-old
hypertensive man with 3-vessel disease and moderate impairment of left ventricular function (patient 2). CABG,
Coronary artery bypass grafting.
Fig 9. Predicted survival and reoperation hazard function curves, 1 ITA versus 2 ITAs, for a normotensive 70-
year-old man with normal left ventricular function (patient 3) and a 50-year-old hypertensive man with severe left
ventricular dysfunction and a history of congestive heart failure (patient 4).
however, is not the only important predictor. Fig 9
depicts outcomes for 2 patients with 3-vessel disease
and class III angina. Patient 3 is a 70-year-old man with
normal left ventricular function and patient 4 is 50
years old with severe left ventricular dysfunction, a his-
tory of hypertension, and heart failure. Both patients
are predicted to have improved survival with bilateral
ITA grafting (patient 4 more than patient 3), and
although both patients are also at a decreased risk of
reoperation with bilateral ITA grafting, again, patient 4
benefits more than patient 3.
Discussion
Few randomized prospective studies have been con-
ducted concerning any of the variations in the basic
strategies of coronary bypass surgery. However, a myri-
ad of observational data has confirmed the effectiveness
of the LITA-LAD graft in terms of superior long-term
patency and its importance clinically in decreasing the
risks of late death and cardiac events after bypass
surgery, even when used in conjunction with saphenous
vein grafts to the circumflex and RCA systems.1-4 On
the basis of logic, many surgeons have used simultane-
ous bilateral ITA grafts for selected patients. However,
although the use of that strategy dates back to the early
years of bypass surgery, the idea that it will improve
long-term outcomes has not been supported by convinc-
ing clinical data, despite the efforts of a number of expe-
rienced investigators.5-8,12-15,24-26
A major issue in the investigation of the relative ben-
efits of single versus bilateral ITA grafting is patient
selection. Even advocates of bilateral ITA grafting have
not used this strategy for all patients, and the possibili-
ty that differences in long-term outcomes are based on
patient-related variables or the period of the operation
rather than operative strategy must be realistically con-
sidered. Our bias against using bilateral ITA grafts dur-
ing emergency operations during the period of this
study was so strong that we excluded patients undergo-
ing emergency surgery from analysis. Diabetic patients
and women were less likely to receive 2 ITA grafts, but
the differences were small (diabetic: bilateral ITA 11%,
single ITA 13%; female: bilateral ITA 11%, single ITA
16%). Advanced age also had a negative correlation
with the use of bilateral ITA grafts, based mainly on
smaller numbers of patients over 70 years of age in the
bilateral ITA group. Also, the use of 2 ITA grafts was
not consistent throughout the time period of the study.
Until approximately 1980 the use of 2 ITA grafts was
limited to situations in which venous conduits were not
available or for extremely young patients. Thus some
patients in the bilateral ITA group have been followed
up for more than 20 years, but the median follow-up of
the bilateral ITA group was just over 10 years, and
fewer than 100 patients were followed for more than 13
years. Conclusions from this study are most valid for a
12-year time frame. 
The ideal way to eliminate bias in the selection of
treatment is to conduct a randomized clinical trial.
Randomization should neutralize selection bias and
allow comparison of treatment strategies for equal
patient subsets. However, substantial difficulties are
associated with the concept of a randomized trial com-
paring single ITA versus bilateral ITA grafting. The
experience of the Coronary Artery Surgery Study
(CASS) and the Bypass Surgery Angioplasty Re-
vascularization Investigation (BARI) has taught us that
selection bias is profound in randomized trials, but that
selection bias is exerted at the point of inclusion into
the trial rather than at the point of treatment choice.
Expense is a major issue associated with these large tri-
als, and even if funding and participants were available
today, 10-year results would not be available for at least
15 years.
The standard of randomized clinical trials can be
achieved only partially in nonrandomized comparisons.
Coupling comparisons with traditional risk factor
analysis adjusts for at least some factors related to
selection so long as they also influence outcome.
However, this gives rise to the question of confounding
selection with outcome. 
The most common method for obtaining comparable
but nonrandomized groups has been by matching.
Matching tends to be done on only a few variables,
since matching on multiple variables quickly tends to
fail to find suitable matches, and, therefore, neither
maximizes the available pool of patients for compari-
son, nor extensively matches them. Further, if one
matches on variables known to influence outcome,
these variables tend not to be able to be used as adjust-
ments in the comparison. In this study the method of
matching was according to propensity score. The
strength of matching using the propensity score is that
it simultaneously matches on all known characteristics,
allows all variables to be used as risk factors, and max-
imizes the use of patients. However, sometimes one
finds subsets of patients that have either an extremely
low or high propensity for one or the other arms of the
comparison and cannot be used. Thus, in this study
matching according to propensity score eliminated
3976 of the single ITA patients from the propensity-
matched analyses because their propensity scores pre-
dicted they were poorly comparable with the bilateral
ITA patients. Recently, the propensity score has been
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incorporated into multivariable comparison analyses as
a variable, as in our study, although its properties are
debated.27 This creates a hybrid model in which most
of the values for variables in the model are from each
individual patient, but also each patient has a variable
whose score is determined by the general behavior of
the overall group, namely, the propensity score.
Importantly, this strategy does not produce a model that
can be readily used for outcome prediction, as is true of
traditional risk factor models. The limitation of all
matching schemes, including propensity scores, is that
the matching is done for known sources of selection
bias, but cannot protect against unknown sources of
selection basis, as do randomized trials.
In the hope of analyzing outcomes in ways that are
both accurate and understandable, we have used multi-
ple statistical strategies and have presented the results
in multiple ways. Unadjusted late survival and reoper-
ation-free survival curves for the entire patient sample
are contained in Fig 1, and the unadjusted survival
curves and reoperation hazard curves for the propensi-
ty-matched patients are in Fig 2. Unadjusted curves for
the propensity-matched patients in regard to the risk
factors of age, diabetes, and left ventricular function
are contained in Figs 5, 6, and 7. We have generated
traditional parsimonious risk factor models for the
entire patient group (Table II), parsimonious models
for propensity-matched patients (Tables V, VI, and VI),
and nonparsimonious models maximally incorporating
all available variables as well as their propensity scores
(Table III). Each type of model has advantages and dis-
advantages. The use of parsimonious risk factor mod-
els enables the identification of multiple risk factors
that affect outcome and allows the production of mod-
els that can be used for outcome prediction. For the
overall comparison of the surgical strategy of 1 versus
2 ITA grafts, nonparsimonious models offer the most
conservative and reliable estimates because all avail-
able variables including the propensity score are
included. The bootstrap resampling adjustment of the
estimates is an attempt to make the comparisons even
more conservative.
Every comparison has shown better outcomes for
patients with bilateral ITA grafts. Multiple statistical
techniques have been used in efforts to reject the idea
that bilateral ITA grafting produces superior outcomes to
single ITA grafting, but all have failed. They all consis-
tently point to a benefit of bilateral ITA grafting, and the
more adjustments that are made for confounding, the
more the increase in the estimated magnitude of the ben-
efit of receiving 2 ITA grafts. The answer to the simple
question, “Are 2 ITA grafts better than one?” is “Yes.”
Substantial effort was made to quantify the extent of
benefit of bilateral ITA grafting. Fig 4 illustrates the
predicted distribution of outcome improvement over
the first 12 postoperative years based on 1 versus 2 ITA
grafts using multivariate techniques that included all
patient information for the propensity-matched groups.
Over that period, bilateral ITA grafting prevented reop-
eration more than it prevented death. For half of the
patient sample, the improvement in the survival based
on bilateral ITA grafting was predicted to be less than
6% (0.5% per year of follow-up). 
For the practicing surgeon, identification of sub-
groups predicted to experience only small benefit from
a more complex surgical technique is obviously use-
ful. Traditionally important risk factors for late sur-
vival (age, diabetes, and left ventricular function) were
examined to see whether these variables could be used
to identify patients without major benefit. Bilateral
ITA grafting achieved better survival regardless of left
ventricular function and regardless of the presence or
absence of treated diabetes. Young patients benefitted
relatively little in terms of survival (over the first 12
postoperative years) but benefitted greatly from bilat-
eral ITA grafting in the avoidance of reoperation and
PTCA. No subgroups were identified that were pre-
dicted to have worse outcomes with bilateral ITA
grafting.
Bilateral ITA grafting improves outcomes for
patients at a high risk of an event. Patients at a high risk
to die have better survival and patients at a high risk of
reoperation and/or PTCA had fewer of these reinter-
ventions. However, the variables that predict the com-
position of high and low benefit groups are multiple, as
depicted in Figs 8 and 9.
It is also important to re-emphasize that this study
basically deals with a 12-year postoperative follow-up
interval. Some patients, particularly in the younger age
group, do not have a substantial increase in their
already favorable survival over 12 years, but there is no
sign that the benefits of bilateral ITA grafting are less-
ening with time, and by 20 postoperative years the
improvement in survival may be much greater.
We examined the details of surgical strategy
(Appendix 2) in both univariate and multivariate set-
tings. Any ITA-LAD graft decreased the risk of death,
reoperation, and PTCA, and there was a slight but sig-
nificant increase in the risk of reoperations for patients
with an ITA–RCA graft. Other studies have also noted
imperfect outcomes with RITA–RCA grafts.28-30 No
other variations in the use of ITA grafts influenced out-
comes. Examination of Appendix 2 will show some
unusual grafting combinations that were usually based
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on unusual situations of coronary anatomy, myocardial
infarction in the distribution of one of the major ves-
sels, or ITA size or anatomy, but also may have been
related to relative surgical inexperience. Our current
strategy is to use the ITA grafts to revascularize the
most important left-sided vessels, sometimes as a com-
posite LITA and RITA “Y” graft. This is a change in
strategy relative to this series and is based in part on the
emergence of other arterial grafts (right gastroepiploic
artery and radial artery) that may be used as grafts to
the RCA. Composite ITA grafting allows more options
in the use of the free RITA but was not used during the
years encompassed in the study. Thus, although this
series may not reflect the ideal use of the ITAs in every
case, it does reflect the results of what was the actual
practice for a consecutive series of patients. It is also
important to note that this is not a study of total arteri-
al revascularization—the majority of patients received
some vein grafts, a factor that may or may not have
compromised outcomes. Today we are more adept at
achieving total arterial revascularization, but whether
that will improve outcomes is not known.
This study has produced different results than previ-
ous studies that have compared single and bilateral ITA
grafting. The simplest possible explanation for this dif-
ference is that this study contains larger numbers of
patients who received bilateral ITA grafts and they have
been followed up for longer postoperative intervals. A
study from Europe by Sergeant, Blackstone, and
Meyns5 that investigated similar issues and contained
large patient numbers showed no advantage for bilater-
al ITA grafting in regard to either survival or reopera-
tion-free survival. However, although that study con-
tained a large number of patients overall, the subset of
patients who had undergone bilateral ITA grafting was
much smaller and their mean postoperative follow-up
interval was only approximately 6 years. Also, differ-
ences between the European and American medical
milieus in the indications for primary bypass surgery
and in the indications for reinterventions may influence
outcomes. Smaller studies from United States centers
have not shown significant survival differences, but
many have shown either significant decreases in late
cardiac events or trends in that direction associated
with bilateral ITA grafting.6,8,12,13
We do not believe that the implication of these data is
that every patient undergoing bypass surgery must
receive bilateral ITA grafts. Emergency operations and
reoperations were excluded from this study, and few
patients over 70 years of age were included. There was
an increased risk of wound complications for diabetic
patients, although that increase in risk was small.
Bilateral ITA grafting makes coronary surgery more
complicated, and the results of this study must be eval-
uated with the realization that the surgeons involved
were experienced in coronary surgery in general and in
complex arterial grafting in particular. Concepts of
coronary surgery continue to evolve, and the advent of
radial artery grafts provides another choice for arterial
revascularization, although the long-term effectiveness
of radial artery grafts remains to be determined.
Opponents of multiple arterial grafting strategies may
argue that there were patients in our study for whom
the incremental benefit of bilateral ITA grafting (at
least over 12 years) may be small, particularly in terms
of survival. Ultimately, for each bypass operation each
individual surgeon must decide what operation that sur-
geon can accomplish for that patient at that time that
will produce the best short- and long-term outcomes.
Many factors must be considered.
However, until now it has been the position of some
coronary artery surgeons that the consideration of mul-
tiple arterial grafting could be ignored because no clear
evidence existed that outcomes were improved for any
patient subsets. That position is no longer tenable. The
data from this study indicate that the strategy of bilat-
eral ITA grafting decreases the risk of death, reopera-
tion, and PTCA when compared to a strategy of single
ITA grafting.
We thank Deborah H. Gladish, BA, and Maura J.
Schnauffer for project management and statistical assistance.
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Discussion
Dr Hendrick B. Barner (St Louis, Mo). It is a pleasure to
discuss this report, which I have long anticipated and which
reflects surgical expertise and dedicated patient follow-up. It
has been 12 years since the report of enhanced survival and
reduced ischemic events when a single ITA is grafted to the
LAD coronary artery. For a number of reasons, the logical
step of showing an advantage for 2 ITAs over 1 ITA has been
more arduous, but the dedication of the Cleveland Clinic sur-
geons has resulted in another landmark paper. 
In most hearts, the LAD is the most important coronary
artery, and it is self-evident that if 2 ITAs are to be proven
better than 1 ITA, the second ITA must be placed to the next
most important coronary artery in terms of the mass of viable
myocardium subtended by that artery. By and large, the
authors have achieved this goal, but not perfectly, since 7% of
the single ITA grafts were placed to the diagonal artery or its
equivalent, and in 13% of patients with bilateral ITA grafting,
1 ITA was placed to the diagonal artery or its equivalent.
Thus 6% more of bilateral ITA patients had placement of 1
ITA to the diagonal artery, which was probably not the sec-
ond most important coronary artery. Had it been placed to a
more important coronary artery, this might have resulted in
even better outcome for the bilateral ITA group.
The modest use of the ITA as a free graft is surprising con-
sidering the Cleveland Clinic was one of the first to report
such use in 1973. As a consequence, the in situ RITA crossed
the midline to reach the left side of the heart in 64% of
patients. I believe your practice has been to bring it across
anteriorly rather than through the transverse sinus, and you
have reported relative success when some of these patients
did require reoperation from the standpoint of injury to the
anterior crossing RITA. In view of the favorable experience
with routine use of the free RITA, as reported by Dr Tatoulis,
has your practice in this regard changed in the last decade? 
The incidence of diabetes was relatively high at 10.8% for
the bilateral group and low at 13% for single ITA use. It is
understandable that this incidence would be low in the bilat-
eral group because of the risk of mediastinitis, but was it low
in the single ITA group because of patient selection? This
raises the issue of a selection by the surgeon, which is prob-
ably the greatest limitation of this study.
Dr Lytle. Let me address the statistical methods first. Two
different statisticians used two different approaches to theses
analyses. Ms Houghtaling used Cox proportional hazard mod-
els of the entire group and selected subgroups, whereas Dr
Blackstone used hazard function and interaction based analy-
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ses. They ended up with almost identical conclusions. I am
very comfortable with the statistical methods used in this study.
In regard to the vessels grafted with the ITA grafts:
Although the LAD coronary artery is usually the most impor-
tant anterior vessel, that is not always the case. In the single
ITA group, 7% of patients received an ITA-diagonal graft,
usually because the diagonal was the most important artery.
These patients may have had a small LAD or a previous LAD
infarct. For the bilateral ITA graft group, in 60% of patients
the LAD and circumflex were the vessels receiving ITA grafts
and in 20% it was the LAD and RCA. The hodgepodge of
other combinations was usually reflective of unusual anatom-
ic situations, a lack of LAD stenosis, or previous myocardial
infarction. Remember, this was a consecutive series.
I share your concerns about patient selection and, indeed,
the tendency to select good-risk patients for bilateral ITA
grafting has always made it difficult to clearly demonstrate
that surgical strategy produces better long-term outcomes.
There is no question that there is a bias to select good-risk
patients for extensive arterial grafting strategies. However, in
this study the baseline differences in the single and bilateral
ITA groups in the prevalence of variables like diabetes, age,
and female gender were relatively small. We attempted to
adjust for those baseline differences with our statistical analy-
ses. It is impossible to ever rule out completely the fact that
the improved survival of the bilateral ITA group was not
based on some good-risk patient-related characteristics that
we did not identify and adjust for. However, although the risk
of late death is less for good-risk patients, previous studies
have clearly shown that the prevalence of late reoperation is
greater for good-risk patients. The patients in the bilateral
ITA group had both fewer late deaths and fewer late reopera-
tions. Thus we cannot have it both ways. If we say that the
patients in the bilateral ITA group were better risk patients, it
would stand to reason that they should have had more reop-
erations rather than fewer reoperations. In my opinion, these
data are suggestive that survival is improved with the bilater-
al ITA strategy compared with a single ITA graft, but I think
that there is no question that the risk of reoperation is a lot
less when 2 ITAs are used.
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Appendix 1. Comparison of baseline variable
between patients with bilateral ITAs (n = 2001) and
patients with a single ITA and an SVG (n = 8123)
2 ITAs: 1 ITA ‡ 1 SVG: c 2
Factor square Frequency (%) Frequency (%) P value
Gender
Male 1786 (89.3) 6815 (83.9) <.001
Female 215 (10.7) 1308 (16.1)
Diabetes
Yes 212 (10.8) 1052 (13.0) .009
No 1750 (89.2) 7054 (87.0)
History of smoking
Yes 766 (42.9) 3102 (43.7) .567
No 1019 (57.1) 4002 (56.3)
History of myocardial 
infarction
Yes 1029 (51.5) 4322 (53.3) .139
No 970 (48.5) 3784 (46.7)
Infarction according 
to electrocardiogram
Yes 651 (32.6) 2560 (31.6) .397
No 1348 (67.4) 5546 (68.4)
Family history of 
coronary artery 
disease
Yes 1129 (70.2) 4221 (66.8) .008
No 479 (29.8) 2103 (33.2)
Extent of disease
Single 35 (1.8) 273 (3.4) <.001
Double 526 (26.3) 2309 (28.4)
Triple 1440 (72.0) 5540 (68.2)
Left ventricular function
None 730 (36.5) 2805 (34.5) <.001
Mild 552 (27.6) 2059 (25.4)
Moderate 277 (13.8) 1282 (15.8)
Severe 442 (22.1) 1977 (24.3)
Appendix 1. Continued
2 ITAs: 1 ITA ‡ 1 SVG: c 2
Factor square Frequency (%) Frequency (%) P value
Left main disease
Yes 269 (13.4) 1001 (12.3) .175
No 1732 (86.6) 7122 (87.7)
LAD ‡ 70% stenosis
Yes 1663 (83.1) 7118 (87.6) <.001
No 338 (16.9) 1005 (12.4)
Peripheral vascular disease
Yes 171 (8.6) 894 (11.0) .001
No 1828 (91.4) 7212 (89.0)
New York Heart 
Association 
functional class
I 368 (18.4) 1260 (15.6) <.001
II 714 (35.7) 2720 (33.5)
III 213 (10.6) 811 (10.0)
IV 706 (35.3) 3319 (40.9)
Age (y)
20-29 2 (0.1) 9 (0.1)
30-39 93 (4.6) 221 (2.7)
40-49 414 (20.7) 1335 (16.4)
50-59 866 (43.3) 2957 (36.4)
60-69 564 (28.2) 2708 (33.3)
70-79 60 (3.0) 865 (10.7)
80-89 2 (0.1) 28 (0.3)
ITA, Internal thoracic artery; SVG, saphenous vein graft.
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Appendix 2. Conduit and vessel data for bilateral
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LITA, Left internal thoracic artery; LAD, left anterior descending coronary
artery; RITA, right internal thoracic artery; Cx, circumflex artery; Dg, diagonal
branch; RCA, right coronary artery.
Appendix 3. Variables examined in multivariable analyses
Demography:
Sex, age (years), weight (kg), height (cm), body surface area (m2), body mass index
Symptoms of reversible ischemia:
Canadian heart class (1-4)
Left ventricular function:
Grade of left ventricular dysfunction (none = 1, mild = 2, moderate = 3, severe = 4), history of congestive heart failure, history of previous 
myocardial infarct
Cardiac comorbidity:
Family history of coronary artery disease
Noncardiac comorbidity:
History of smoking, peripheral vascular disease, chronic pulmonary disease, pharmacologically treated diabetes, treated hypertension
Coronary anatomy:
Left main disease (percent diameter reduction, presence of ‡ 50% stenosis), LAD coronary system disease (percent maximal diameter reduction,
presence of ‡ 50% and ‡ 70% stenosis), circumflex coronary artery system disease (percent maximal diameter reduction, presence of ‡ 50% 
and ‡ 70% stenosis), RCA system disease (percent maximal diameter reduction, presence of ‡ 50% and ‡ 70% stenosis), number of diseased 
systems (‡ 50% criteria)
Coronary operation:
Single versus bilateral use of ITA grafting, ITA to LAD, ITA to RCA, ITA to circumflex
Experience:
Date of operation (number of years since January 1971)
For propensity analysis only:
Surgeon
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Variable BITA SITA P BITA SITA P BITA SITA P
N 110 1913 446 1570 1351 664
Male (%) 82 79 .6 85 83 .2 93 89 .01
Age (y) 61 ± 8.2 60 ± 9.0 .2 59 ± 8.1 59 ± 8.4 .2 54 ± 8.1 56 ± 8.0 <.0001†
Weight (kg) 80 ± 13.4 80 ± 14.0 .98 82 ± 12.9 82 ± 13.8 .4 84 ± 13.5 83 ± 14.9 .5
Left ventricular function (1-4) 2.3 ± 1.16 2.3 ± 1.19 .98 2.3 ± 1.16 2.3 ± 1.20 .7 2.2 ± 1.16 2.2 ± 1.17 .3
Systems diseased (1-3) 2.6 ± 0.54 2.7 ± 0.52 .2 2.7 ± 0.50 2.7 ± 0.51 .96 2.7 ± 0.48 2.7 ± 0.52 .06
Diabetes (%) 11 16 .15 16 14 .3 9 11 .07
Ten-year survival 75 ± 4.5 74 ± 1.1 .4 81 ± 2.0 74 ± 1.2 .005 85 ± 1.0 77 ± 1.8 <.0001
BITA, Bilateral internal thoracic artery; SITA, single internal thoracic artery.
*The first two quintiles encompass only 68 patients with BITA grafts.
†Note: The difference in age is in the ninth decile (56 ± 8.0, n = 507, vs 57 ± 7.8 years, n = 501, P = .01), not in the extreme (tenth) decile (52 ± 7.8 years, n = 844,
vs 53 ± 7.5 years, n = 163, P = .5).
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